Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy

By Correa Denise   Rocco-Donovan Mary   DeAngelis Lisa   Dolgoff-Kaspar Rima   Iwamoto Fabio   Yahalom Joachim   Abrey Lauren  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 315-321

Springer Publishing Company

Access to resources Recommend Favorite

Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy

By Lee Suk-young   Kurita Naoki   Yokoyama Yasuhisa   Seki Masanori   Hasegawa Yuichi   Okoshi Yasushi   Chiba Shigeru  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1385-1390

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy

By Kang Myoung  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3163-3172

Springer Publishing Company

Access to resources Recommend Favorite

Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin’s lymphoma

By Schütt P.   Zimmermann K.   Derks C.   Ebeling P.   Welt A.   Poser M.   Hense J.   Metz K.   Anhuf J.   Sandmann M.   Neise M.   Moritz T.   Stuschke M.   Niederle N.   Seeber S.   Nowrousian Mohammad  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 3, 2009-03 ,pp. : 459-466

Springer Publishing Company

Access to resources Recommend Favorite

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14)

By Adde Magdalena   Enblad Gunilla   Hagberg Hans   Sundström Christer   Laurell Anna  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 283-293

Humana Press, Inc

Access to resources Recommend Favorite